Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbH — Clinical Trial Site

45 Registered trials

16 Currently recruiting

Organisation

Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbH

Location

Essen, Germany

Identifier

ORG-100023615

Address

Tueschener Weg 40, Heidhausen, 45239, Germany

Departments

#2003
09: Interstitielle Lungenerkrankungen
Abteilung Pneumologie und Allergologie
Abteilung Pneumologie-Allergologie
am Universitätsklinikum Essen gGmbH
am Universitätsklinikum Essen gGmbH, Abteilung Pneumologie und Allergologie
Center for interstitial and rare lung diseases
Cystic Fibrosis and Pulmonary Medicine
Department of Pneumology
Interstital and Rare Lung Disease Center
Interstitial and Rare Lung Disease Centre
Klinik fuer Pneumologie
Klinik für Pneumologie
Klink für Pneumologie
N/A
NA
Pneumologie
Ruhrlandklinik - Westdeutsches Lungenzentrum
Ruhrlandklinik - Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH
Ruhrlandklinik Universitätsmedizin Essen
Westdeutsches Lungenzentrum
Zentrum für interstitielle und seltene Lungenerkrankungen

Clinical trials at this site (45)

Search interface

A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending

2024-514246-37-00 Idiopathic pulmonary fibrosis (IPF) 4
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending

2025-523400-72-00 Cystic fibrosis 4
RENEW - A Phase 2 Study of the Safety, Tolerability and Efficacy of LTI-03 in Patients with Idiopathic Pulmonary Fibrosis Recruiting

2025-520715-13-00 Idiopathic Pulmonary Fibrosis 4 2026-04-22
A clinical study to test how safe and effective a new inhaled treatment (called L606) is for people with high blood pressure in the lungs du… Recruiting

2024-517943-29-00 Pulmonary Hypertension associated with interstitial lun 5 2026-04-21
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
A study of the efficacy and safety of Belimumab in adults with interstitial lung disease associated with connective tissue disease. Recruiting

2024-513018-36-00 Lung Diseases, Interstitial 5 2025-03-06
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis Recruiting

2023-503699-25-00 Progressive Pulmonary Fibrosis 5 2024-07-15
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis Recruiting

2023-503697-21-01 Idiopathic pulmonary fibrosis 5 2024-06-24
Clairleaf TM: A study to test long-term treatment with BI 1291583 in people with bronchiectasis who took part in a previous study with this … Recruiting

2023-503290-38-00 Bronchiectasis 4 2023-09-05
A study to test whether nerandomilast can help slow down changes in the lung in people with a family history of pulmonary fibrosis Recruiting

2025-522383-33-00 Pulmonary fibrosis 5 2026-03-23
A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and ch… Recruiting

2025-523009-14-00 Bronchiectasis with chronic pseudomonas aeruginosa colo 4 2025-12-16
A study to find out whether BI 765423 has an effect on lung function in people with idiopathic pulmonary fibrosis (IPF) with or without stan… Recruiting

2025-520658-12-00 Idiopathic Pulmonary Fibrosis (IPF) 4 2025-11-20
A study to test whether nerandomilast helps people with lung fibrosis related to rheumatic diseases Recruiting

2024-512849-17-00 Systemic Autoimmune Rheumatic Diseases associated Inter 5 2025-11-14
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A phase IIa, randomized, placebo-controlled, double-blind, cross-over study to evaluate safety and efficacy of subcutaneous administration o… Recruiting

2023-510376-31-00 Cystic fibrosis 4 2022-10-05
Inhalation therapy in adult bronchiectasis patients with new asymptomatic Pseudomonas aeruginosa infection– an open-label, proof of concept … Recruiting

2023-509277-22-00 Bronchiectasis 4 2022-06-22
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis Ended

2023-509069-19-00 idiopathic pulmonary fibrosis 4 2024-12-12
A Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis Ended

2023-508429-29-00 Progressive Pulmonary Fibrosis 4 2024-09-26
A Randomized, Double Blind, Active-Controlled Study on Efficacy and Safety of TEV-56248 in Patients with Asthma Ended

2023-505435-12-00 Asthma 5 2024-06-04
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Fibrotic Lung Disease 5 2024-03-01
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Ended

2024-514173-22-00 Cystic Fibrosis 5 2023-02-28
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del Ended

2024-515637-14-00 Cystic Fibrosis 5 2022-11-08